Biofourmis: Funding, Investors & Team (Oct 2026)
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
Biofourmis has raised $420M across 3 funding rounds on record, the most recent a Series D of $20.0M announced in Jul 2022.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Biofourmis Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Biofourmis Funding Rounds
Biofourmis raised $100M in an undisclosed round announced in Sep 2020.
1.6 years later, a Series D of $300M was announced in Apr 2022.
3 months later, a Series D of $20.0M was announced in Jul 2022.
Biofourmis Founders and Leadership Team
Contact details for the Biofourmis team: 1 of 2 have an email address on file.
Start 14-day free trial →Biofourmis Funding Compared to Other Artificial Intelligence Startups
Biofourmis' latest round of $20.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biofourmis in Artificial Intelligence and Boston
Companies Similar to Biofourmis
Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native platform…
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to…
RapidCanvas is an AI platform that combines the precision and automation of AI agents with the deep domain…
Labelbox is a collaborative data training platform that creates and manages labeled data for machine learning…
Clueso is an AI-driven support system for SaaS applications.
Dapta is a software-as-a-service company that provides a platform with minimal coding required to create APIs…
Factored was co-founded with renowned AI expert Andrew Ng (Stanford/AI Fund/Google Brain/Coursera) and…
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor…
Lightsprint provides an AI-native product development platform that supports collaborative software…
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is…
Drylab is an AI-powered bioinformatics platform for biomedical data analysis, research workflows, and…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Biofourmis Funding FAQs
What does Biofourmis do?
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
How much funding has Biofourmis raised?
Biofourmis has raised $420M across 3 rounds on record. The most recent is a Series D of $20.0M announced in Jul 2022.
When did Biofourmis last raise funding?
Biofourmis' most recent funding round on record is a Series D of $20.0M, announced in Jul 2022.
Who founded Biofourmis?
FundedIQ lists Maulik Majmudar (Founder) at Biofourmis.
Who is the CEO of Biofourmis?
Kuldeep Singh Rajput is listed as CEO at Biofourmis.
Where is Biofourmis headquartered?
Biofourmis is based in Boston, Massachusetts, United States.
How many employees does Biofourmis have?
Biofourmis is in the 251-500 employee band.
How does Biofourmis' funding compare to other Artificial Intelligence startups?
Biofourmis' latest round of $20.0M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,243 tracked companies over the last two years.
About FundedIQ's Biofourmis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biofourmis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.